Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
General Surgery · BAD AXE, MI · NPI 1053497149
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 404 | 65 |
| Atorvastatin Calcium | Atorvastatin Calcium | 374 | 99 |
| Levothyroxine Sodium | Levothyroxine Sodium | 297 | 72 |
| Furosemide | Furosemide | 272 | 70 |
| Gabapentin | Gabapentin | 271 | 53 |
| Potassium Chloride | Potassium Chloride | 230 | 60 |
| Metoprolol Tartrate | Metoprolol Tartrate | 222 | 73 |
| Tamsulosin Hcl | Tamsulosin Hcl | 208 | 51 |
| Amlodipine Besylate | Amlodipine Besylate | 185 | 42 |
| Sertraline Hcl | Sertraline Hcl | 138 | 40 |
| Lisinopril | Lisinopril | 134 | 43 |
| Losartan Potassium | Losartan Potassium | 120 | 36 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 119 | 18 |
| Metformin Hcl | Metformin Hcl | 117 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 115 | 30 |
| Trazodone Hcl | Trazodone Hcl | 102 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 100 | 34 |
| Metoprolol Succinate | Metoprolol Succinate | 99 | 25 |
| Carvedilol | Carvedilol | 91 | 22 |
| Tramadol Hcl | Tramadol Hcl | 90 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 88 | 20 |
| Omeprazole | Omeprazole | 87 | 39 |
| Farxiga | Dapagliflozin Propanediol | 86 | suppressed |
| Levetiracetam | Levetiracetam | 86 | 16 |
| Lorazepam | Lorazepam | 85 | 27 |
| Sodium Chloride | 0.9 % Sodium Chloride | 84 | 19 |
| Donepezil Hcl | Donepezil Hcl | 80 | 20 |
| Pantoprazole Sodium | Pantoprazole Sodium | 78 | 39 |
| Divalproex Sodium | Divalproex Sodium | 73 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 73 | 34 |
| Buspirone Hcl | Buspirone Hcl | 72 | 19 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 69 | 29 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 69 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 66 | 19 |
| Olanzapine | Olanzapine | 66 | 15 |
| Memantine Hcl | Memantine Hcl | 64 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 61 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 61 | 14 |
| Xarelto | Rivaroxaban | 61 | 11 |
| Cephalexin | Cephalexin | 58 | 26 |
| Famotidine | Famotidine | 54 | 17 |
| Baclofen | Baclofen | 52 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 50 | 13 |
| Mirtazapine | Mirtazapine | 50 | 20 |
| Finasteride | Finasteride | 49 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 47 | 20 |
| Bumetanide | Bumetanide | 46 | 19 |
| Risperidone | Risperidone | 45 | 11 |
| Allopurinol | Allopurinol | 43 | 20 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 43 | 14 |
| Prednisone | Prednisone | 43 | 19 |
| Oxycodone Hcl | Oxycodone Hcl | 42 | suppressed |
| Trulicity | Dulaglutide | 42 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 40 | 21 |
| Glipizide | Glipizide | 40 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 39 | 15 |
| Bethanechol Chloride | Bethanechol Chloride | 36 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 36 | 11 |
| Jardiance | Empagliflozin | 35 | suppressed |
| Spironolactone | Spironolactone | 35 | 11 |
| Atropine Sulfate | Atropine Sulfate | 34 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | 13 |
| Divalproex Sodium Er | Divalproex Sodium | 33 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Simvastatin | Simvastatin | 33 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 32 | 20 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 31 | 31 |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Insulin Lispro | Insulin Lispro | 28 | suppressed |
| Januvia | Sitagliptin Phosphate | 28 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 28 | 14 |
| Propranolol Hcl | Propranolol Hcl | 28 | suppressed |
| Sucralfate | Sucralfate | 27 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 26 | suppressed |
| Myrbetriq | Mirabegron | 25 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 25 | suppressed |
| Alprazolam | Alprazolam | 24 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 23 | 12 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | suppressed |
| Clonazepam | Clonazepam | 22 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 21 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 21 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 21 | suppressed |
| Ezetimibe | Ezetimibe | 21 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 21 | 12 |
| Brilinta | Ticagrelor | 20 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Meloxicam | Meloxicam | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 18 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Rexulti | Brexpiprazole | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | suppressed |
| Atenolol | Atenolol | 17 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Enulose | Lactulose | 17 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 17 | suppressed |
| Paliperidone Er | Paliperidone | 17 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Amantadine | Amantadine Hcl | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Multaq | Dronedarone Hcl | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 11 |
| Scopolamine | Scopolamine | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error